Resalis Therapeutics secured a strategic equity investment from Sanofi to accelerate the development of its lead candidate, RES-010, through a Phase 2 clinical trial.
Round Type
Venture
TurinBiotechnologyInvestors
Description
Resalis Therapeutics announced a strategic equity investment from Sanofi to fast-track the development of RES-010, aimed at obesity treatment. This investment validates their approach and supports advancements towards clinical trials offering potential transformative treatments for obesity.
Quick answer
Resalis Therapeutics raised an undisclosed amount in a funding round, dated October 28, 2024. Investors: Sanofi. Resalis Therapeutics is based in Turin, Piedmont, Italy.
- How much did Resalis Therapeutics raise?
- Resalis Therapeutics raised an undisclosed amount in a funding round on October 28, 2024.
- Who invested in Resalis Therapeutics?
- Sanofi is named as investors in this round.
- What does Resalis Therapeutics do?
- Resalis Therapeutics’ transformative metabolic disease approach targets a master regulator of multiple pathways underlying obesity and fatty liver disease.
- Where is Resalis Therapeutics based and how big is it?
- Resalis Therapeutics is based in Turin, Piedmont, Italy.
- Who are the decision-makers at Resalis Therapeutics?
- Fundz holds 1 contact at Resalis Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as Resalis Therapeutics that raised within 45 days of this round, from Fundz verified event records.
Who to call at Resalis Therapeutics, and when
A new round usually means Resalis Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Resalis Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Resalis Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Resalis Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Resalis Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Resalis Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.